PUBLIC HEALTH GUIDANCE SCOPE
|
|
- Gavin Blankenship
- 7 years ago
- Views:
Transcription
1 NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE PUBLIC HEALTH GUIDANCE 1 Guidance title SCOPE Prevention of type 2 diabetes: prevention of the progression of pre-diabetes to type 2 diabetes among adults in high-risk groups 1.1 Short title 2 Background a) The National Institute for Health and Clinical Excellence (NICE) has been asked by the Department of Health (DH) to develop guidance on a public health programme aimed at preventing type 2 diabetes mellitus among high-risk groups. The referral has been divided into two separate pieces of complementary guidance. b) This guidance will address the prevention of the progression from pre-diabetes (or impaired blood glucose regulation) to type 2 diabetes among high risk individuals and groups. The other guidance will address the prevention of pre-diabetes among populations and communities at greatest risk, including determinants of health such as environments that support behaviour change. c) NICE public health guidance supports the preventive aspects of relevant national service frameworks (NSFs), where they exist. If it is published after an NSF has been issued, the guidance effectively updates it. Specifically, in this case, the guidance will support NSFs on the following: coronary heart disease and diabetes (DH 2000; 2001; 2002). final scope Page 1 of 17
2 d) This guidance will support a number of related policy documents including: Equity and excellence: liberating the NHS (DH 2010a) Fair society, healthy lives. Strategic review of health inequalities in England post 2010 (Marmot 2010) Healthy weight, healthy lives: a cross-government strategy for England (DH 2008a) Six years on: delivering the diabetes national service framework (DH 2010b) National stroke strategy (DH 2007) Putting prevention first NHS health check: vascular risk assessment and management best practice guidance (DH 2009) Putting prevention first vascular checks: risk assessment and management (DH 2008b) Securing good health for the whole population (Wanless 2004) e) This guidance will provide recommendations for good practice, based on the best available evidence of effectiveness, including cost effectiveness. It is aimed at professionals, commissioners and managers with public health as part of their remit working within the NHS, local authorities and the wider public, private, voluntary and community sectors. It is particularly aimed at directors of public health, GPs and other doctors, practice nurses, dietitians, public health nutritionists, pharmacists, physiotherapists, podiatrists, optometrists, dentists and others who work in the community, private and voluntary sectors such as those involved in running slimming clubs, health trainers and fitness instructors. It will also be of interest to people diagnosed with pre-diabetes or who are at risk of developing pre-diabetes and their families and carers and other members of the public. final scope Page 2 of 17
3 f) The guidance will complement NICE guidance on diabetes, behaviour change, obesity, cardiovascular disease, physical activity and maternal and child nutrition. For further details, see section 6. This guidance will be developed using the NICE public health programme process. 3 The need for guidance a) The number of people aged 16 and older with diabetes (diagnosed and undiagnosed) in the UK in 2010 is estimated at approximately 3.1 million. It is estimated that between 2010 and 2030 the prevalence of diabetes in this age group will increase to 4.6 million, or 9.5% of the population. It is predicted that around half of these cases will result from the increasing prevalence of obesity; the other half from the ageing population and changes in ethnic grouping (Yorkshire and Humber Public Health Observatory 2010). b) Diabetes is one of the most prevalent and costly chronic diseases. The complications arising from the disease are associated with damage to the eyes, kidneys and nerves. People with type 2 diabetes have an increased risk of coronary heart disease, peripheral vascular disease and stroke and they are more likely to have hypertension, dyslipidaemia (abnormal blood lipid and lipoprotein levels) and obesity. In England people aged between 20 and 79 years with diabetes are more than twice as likely to die as people without diabetes (Yorkshire and Humber Public Health Observatory 2008). c) People who are overweight or obese are more likely to develop type 2 diabetes, and the risk rises as body weight increases (The DECODE Study Group 2002). d) Diabetes is more prevalent among people of African Caribbean, black African and Asian descent living in the UK than among the final scope Page 3 of 17
4 white population. In these groups diabetes also tends to develop at a younger age (DH 2006). e) Pre-diabetes occurs when glucose levels are higher than the normal range on a sustained basis, but are not high enough to be diagnosed as diabetes. Like diabetes, pre-diabetes is characterised by insulin resistance and impaired insulin secretion. People with pre-diabetes have impaired fasting glucose (IFG) or impaired glucose tolerance (IGT) or they may have both conditions. f) Pre-diabetes is associated with an increased risk of developing type 2 diabetes, but progression to diabetes is not inevitable. More than half of Europeans may have IFG or IGT during their lifetime (The DECODE Study Group 2003). The average risk of developing type 2 diabetes increases from 0.7% per year in those with normal blood glucose levels to between 5% and 10% per year in those with IFG or IGT. Those with both IFG and IGT are twice as likely to develop diabetes as those with either IFG or IGT (Aroda and Ratner 2008). Progression rates from IGT vary with ethnicity, with some black and minority ethnic groups progressing to diabetes at more than twice the rate of white populations (Ramachandran et al. 2006). However, it is possible to move from a pre-diabetic state back to the normal blood glucose range. g) People with pre-diabetes have no symptoms of illness so it can remain unrecognised for years. However, the microvascular changes associated with diabetes may have already developed. In the Diabetes Prevention Programme 8% of those with IGT had signs of diabetic retinopathy (Diabetes Prevention Programme Research Group 2007). There is a linear increase of cardiovascular disease with increasing blood glucose levels both when the blood glucose values are lower than the criteria for diagnosis of type 2 diabetes and in the normal range (The American College of Endocrinology and the American Association of Clinical Endocrinologists 2008). Cardiovascular risk in pre-diabetes may be final scope Page 4 of 17
5 almost twice that for people without IFG or IGT. Progression from IFG to diabetes results in a further doubling of the risk (The American College of Endocrinology and the American Association of Clinical Endocrinologists 2008). 4 The guidance Public health guidance will be developed according to NICE processes and methods. For details see section 5. This document defines exactly what this guidance will (and will not) examine, and what the guidance developers will consider. The scope is based on a referral from the DH (see appendix A). 4.1 Who is the focus? Groups that will be covered a) Adults aged 18 years and over with a diagnosis of pre-diabetes using current World Health Organization criteria (World Health Organization 2006), that is either or both: Impaired fasting glucose (IFG) Fasting plasma glucose (FPG) between 6.1 and 6.9 mmol/litre Impaired glucose tolerance (IGT) FPG less than 7.0 mmol/litre and a plasma glucose (2 hours after ingestion of a 75 g oral glucose load, the oral glucose tolerance test) between 7.8 and 11.0 mmol/litre. IFG and IGT can occur as isolated conditions or in combination. The diagnostic criteria for IFG and IGT and type 2 diabetes are expected to be revised by the World Health Organization in final scope Page 5 of 17
6 b) The guidance will focus on people who: are of south Asian, African Caribbean, Chinese or black African descent and older than 25 years, or white and aged 40 years or older, and who have one or more of the following characteristics: obesity (a body mass index [BMI] of 30 kg/m 2 or above, or 27.5 kg/m 2 or above if of south Asian or Chinese descent) a waist circumference: greater than 80 cm for women of European or African descent greater than 94 cm for men of European or African descent equal to or greater than 80 cm for women of south Asian or Chinese descent equal to or greater than 90 cm for men of south Asian or Chinese descent (Alberti et al. 2007) a history of cardiovascular disease abnormal blood lipids or lipoprotein level (for example low high-density lipoprotein [HDL] cholesterol) hypertension a first-degree relative with type 2 diabetes sedentary lifestyle. c) If the evidence allows, people with the following characteristics will be covered: severe mental health problems learning disabilities taking medication that can increase the risk of developing diabetes such as steroids, antiretrovirals and some antipsychotics polycystic ovary syndrome low birth weight, that is less than 2.5 kg (5.5 lbs) women with a history of diabetes in pregnancy and women who have had a baby that weighed more than 4.5 kg (9 lbs) at birth. final scope Page 6 of 17
7 4.1.2 Groups that will not be covered People younger than 18. People with a diagnosis of type 2 diabetes or other forms of diabetes. Pregnant women. 4.2 Activities Activities/measures that will be covered a) Interventions delivered at individual, family, community and population levels in primary, secondary and tertiary care, the community, residential care sector, and prisons including: Risk assessment, identification and monitoring of adults with IFG/IGT or raised glycated haemoglobin (HbA 1c ). Lifestyle interventions involving any or all of the following: weight-loss strategies (for example, motivational support, slimming clubs) diet (for example, low glycaemic index, reduced fat, controlled carbohydrate, low calorie diets) physical activity (for example, cardiorespiratory training, organised programmes, individual programmes). Pharmacological interventions to reduce hyperglycaemia, according to their licensed indications 1 (for example, metformin, thiazolidinediones) or weight loss medication (for example, orlistat) either alone or with lifestyle interventions. 1 Recommendations will normally fall within licensed indications but exceptionally, and only if clearly supported by evidence, use outside a licensed indication may be recommended. The guidance will assume that prescribers will use a drug s summary of product characteristics to inform decisions made with individual patients. final scope Page 7 of 17
8 Surgical intervention to aid weight loss (for example, gastric banding) either alone or with pharmacological or lifestyle interventions. b) The guidance will use a public sector perspective, that is, considering NHS and other public sector costs. c) The Programme Development Group will take reasonable steps to identify ineffective measures and approaches Activities/measures that will not be covered Treatment and management of type 2 diabetes, gestational diabetes or any other form of diabetes. (Type 1 diabetes, type 2 diabetes and diabetes in pregnancy are the subjects of previously published NICE guidance, see section 6.) 4.3 Key questions and outcomes Below are the overarching questions that will be addressed, along with some of the outcomes that would be considered as evidence of effectiveness: Questions: What are the most effective and cost-effective methods of identifying and monitoring adults with either or both IFG and IGT? What are the most effective and cost-effective methods lifestyle, pharmacological and surgical of preventing or delaying type 2 diabetes in adults with pre-diabetes? How do the effectiveness and cost effectiveness of interventions vary between different communities or groups, including disadvantaged groups? Which interventions or strategies, and which combinations of interventions or strategies, are the most effective and cost effective in preventing or delaying type 2 diabetes in adults with pre-diabetes within a given community? final scope Page 8 of 17
9 What are the barriers and facilitators that may affect the implementation, effectiveness and cost effectiveness of these interventions or strategies (this should include any barriers and facilitators for specific groups)? Expected outcomes: Prevalence and incidence of type 2 diabetes. Physiological measures: glucose levels (fasting, 2-hour post-glucose load and HbA 1c ), lipid levels (total cholesterol, low density lipoprotein [LDL] and HDL-cholesterol, triglycerides), systolic and diastolic blood pressure aerobic capacity, exercise tolerance tests. Diabetes and cardiovascular and microvascular-related morbidities: vascular disease angina pectoris, myocardial infarction, stroke, peripheral vascular disease and its consequences (such as the need for amputation) microvascular changes and progression to neuropathy, retinopathy, nephropathy autonomic dysfunction erectile dysfunction, pain, sweating. Anthropometric measures: body weight weight loss BMI waist circumference measurement skin fold thickness. Measures of quality of life. Mental wellbeing: depression anxiety. final scope Page 9 of 17
10 All-cause mortality. Take-up of and adherence to the intervention: frequency, duration and intensity of physical activity dietary constituents, calorie intake. Adverse effects (for example traumatic injuries secondary to leisure physical activity, nutritional deficits, side effects of drugs or surgery). For economic modelling, estimates of length of life and quality of life with and without an intervention will be needed to estimate quality-adjusted life years (QALYs). More information about these terms is available at Intermediate outcomes Knowledge. Beliefs. Self efficacy, locus of control. Comparators used to judge effectiveness and cost effectiveness will include: no intervention similar interventions, for example different types of dietary intervention, different methods of delivering the same intervention different interventions, for example diet versus exercise, lifestyle interventions versus pharmacological or surgical interventions comparing single interventions with packages of interventions. 4.4 Status of this document This is the final scope, incorporating comments from a 4-week consultation, which included a stakeholder meeting on 19 May final scope Page 10 of 17
11 5 Further information The public health guidance development process and methods are described in The NICE public health guidance development process: An overview for stakeholders including public health practitioners, policy makers and the public (second edition, 2009) available at and Methods for development of NICE public health guidance (second edition, 2009) available at 6 Related NICE guidance Published Type 2 diabetes newer agents (partial update of CG66). NICE clinical guideline 87 (2009). Available from Type 2 diabetes. NICE clinical guideline 66 (2008). Available from Diabetes in pregnancy. NICE clinical guideline 63 (2008). Available from Obesity. NICE clinical guideline 43 (2006). Available from Type 1 diabetes. NICE clinical guideline 15 (2004). Available from Diabetes (type 1 and 2) patient education models. NICE technology appraisal guidance 60 (2003). Available from Prevention of cardiovascular disease. NICE public health guidance 25 (2010). Available from Under development Hyperglycaemia in acute coronary syndromes. NICE clinical guideline. Publication date to be confirmed. final scope Page 11 of 17
12 Type 2 diabetes: preventing pre-diabetes in adults. NICE public health guidance. Publication expected June Preventing obesity: a whole-system approach. NICE public health guidance Publication expected March final scope Page 12 of 17
13 Appendix A Referral from the Department of Health The Department of Health asked NICE to: 'produce public health programme guidance for the health service on the prevention of type 2 diabetes mellitus among high-risk groups'. final scope Page 13 of 17
14 Appendix B Potential considerations It is anticipated that the Programme Development Group (PDG) will consider the following issues: The ability to identify IFT and IGT has led to the definition of criteria for the state of pre-diabetes. It is not known how people respond to knowing whether their blood glucose levels meet these criteria. Pre-diabetes is an unstable state there is a natural variation in blood glucose levels. Therefore, a person may naturally fluctuate in and out of the state. There is potential for significant improvement in blood glucose levels leading to reversal to blood glucose levels within the normal range. Glucose levels normally fluctuate during the day and are variable from day to day. This means that a single measurement that is at the extremes of a person s normal range can result in inaccurate classification as being, or not being, pre-diabetic. If self-report measures are used there is a risk of selective reporting, for example food portions and quantities may be under-reported and physical activity overestimated. final scope Page 14 of 17
15 Appendix C References Alberti KGMM, Zimmet P, Shaw J (2007) International Diabetes Federation: A consensus on type 2 diabetes prevention. Diabetic Medicine 24: Aroda VR, Ratner R (2008) Approach to the patient with prediabetes. Journal of Clinical Endocrinology and Metabolism 93: Department of Health (2000) National service framework for coronary heart disease. London: Department of Health Department of Health (2001) Modern standards and services models. National service framework for diabetes: standards. London: Department of Health Department of Health (2002) National service framework for diabetes: standards supplementary information: Health inequalities in diabetes. London: Department of Health Department of Health (2006) Health survey England 2004: The health of minority ethnic groups. London: Department of Health Department of Health (2007) National stroke strategy. London: Department of Health Department of Health (2008a) Healthy weight, healthy lives: a crossgovernment strategy for England. London: Department of Health Department of Health (2008b) Putting prevention first vascular checks: risk assessment and management. London: Department of Health Department of Health (2009) Putting prevention first NHS health check: vascular risk assessment and management best practice guidance. London: Department of Health Department of Health (2010a) Equity and excellence: liberating the NHS. London: Department of Health final scope Page 15 of 17
16 Department of Health (2010b) Six years on: delivering the diabetes national service framework. London: Department of Health Diabetes Prevention Programme Research Group (2007) The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the diabetes prevention programme. Diabetes Medicine 24: Marmot M (2010) Fair society, healthy lives. Strategic review of health inequalities in England post 2010 [online]. Available from Ramachandran A, Snehalatha C, Mary S et al. (2006) The Indian diabetes prevention programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49: The American College of Endocrinology and the American Association of Clinical Endocrinologists (2008) Diagnosis and management of prediabetes in the continuum of hyperglycemia when do the risks of diabetes begin? A consensus statement. Endocrine Practice 14: The DECODE Study Group (2002) Age, body mass index and glucose tolerance in 11 European population-based surveys. Diabetic Medicine 19: The DECODE Study Group (2003) Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 26: 61 9 Wanless D (2004) Securing good health for the whole population. London: HM Treasury World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation. Available from diabetes_new.pdf final scope Page 16 of 17
17 Yorkshire and Humber Public Health Observatory (2008) Diabetes attributable deaths: estimating the excess deaths among people with diabetes [online]. Available from Yorkshire and Humber Public Health Observatory (2010) APHO diabetes prevalence model for England Available from final scope Page 17 of 17
SHORT CLINICAL GUIDELINE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SHORT CLINICAL GUIDELINE SCOPE 1 Guideline title Type 2 diabetes: newer agents for blood glucose control in type 2 diabetes 1.1 Short title Type 2
More informationGuidelines for the management of hypertension in patients with diabetes mellitus
Guidelines for the management of hypertension in patients with diabetes mellitus Quick reference guide In the Eastern Mediterranean Region, there has been a rapid increase in the incidence of diabetes
More informationType 2 Diabetes workshop notes
Group 1 notes Abi / Nicole Type 2 Diabetes workshop notes 4.1 Population The group discussed the following sub groups that may need addressing: Men-as they tend to die earlier compared with women, their
More informationTYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
More information4. Does your PCT provide structured education programmes for people with type 2 diabetes?
PCT Prescribing Report Drugs used in Type 2 Diabetes Discussion Points 1. Does your PCT have a strategy for prevention of type 2 diabetes? Does your PCT provide the sort of intensive multifactorial lifestyle
More informationDIABETES YOUR GUIDE TO
YOUR GUIDE TO DIABETES b What is diabetes? b Type 2 diabetes prevention b Prevention checklist b Living with diabetes b Complications b Terms to know b Resources To promote and protect the health of Canadians
More informationInsulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
More informationPreventing type 2 diabetes: risk identification and interventions for individuals at high risk
Preventing type 2 diabetes: risk identification and interventions for individuals at high risk Issued: July 2012 guidance.nice.org.uk/ph38 NICE 2012 Contents Introduction: scope and purpose of this guidance...
More informationDiabetes: Factsheet. Tower Hamlets Joint Strategic Needs Assessment 2010-2011. Executive Summary. Recommendations
Diabetes: Factsheet Tower Hamlets Joint Strategic Needs Assessment 2010-2011 Executive Summary Diabetes is a long term condition that affects 11,859 people in Tower Hamlets, as a result of high levels
More informationTreatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.
National Diabetes Statistics What is diabetes? Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.
More informationThis information explains the advice about type 2 diabetes in adults that is set out in NICE guideline NG28.
Information for the public Published: 2 December 2015 nice.org.uk About this information NICE guidelines provide advice on the care and support that should be offered to people who use health and care
More informationNutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT
1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:
More information嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
More informationEthnic Minorities, Refugees and Migrant Communities: physical activity and health
Ethnic Minorities, Refugees and Migrant Communities: physical activity and health July 2007 Introduction This briefing paper was put together by Sporting Equals. Sporting Equals exists to address racial
More informationCauses, incidence, and risk factors
Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,
More informationMortality Associated with Diabetes
Mortality Associated with Diabetes A review paper prepared for the 7th Global Conference of Actuaries, New Delhi, 15-16 February, 2005 Dr. David Muiry, MB;BS, FIA, FASI David_Muiry@swissre.com Introduction
More informationScottish Diabetes Survey 2014. Scottish Diabetes Survey Monitoring Group
Scottish Diabetes Survey 2014 Scottish Diabetes Survey Monitoring Group Contents Table of Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 21 Duration
More informationDiabetes and Hypertension Care For Adults in Primary Care Settings
and Hypertension Care For Adults in Primary Care Settings What is Type 2? The carbohydrates including sugar and starch which we take become glucose after digestion. It will then be absorbed by the small
More informationMarkham Stouffville Hospital
Markham Stouffville Hospital Adult Diabetes Education Frequently Asked Questions What is diabetes? Diabetes is a disease in which blood glucose levels are above normal. Most of the food we eat is turned
More informationFamily History and Diabetes. Practical Genomics for the Public Health Professional
Family History and Diabetes Practical Genomics for the Public Health Professional Outline Overview of Type 2 Diabetes/Gestational Diabetes Familial/Genetic Nature of Diabetes Interaction of Genes and Environment
More informationThe Burden Of Diabetes And The Promise Of Biomedical Research
The Burden Of Diabetes And The Promise Of Biomedical Research Presented by John Anderson, MD Incoming Chair, ADA s National Advocacy Committee; Frist Clinic, Nashville, TN Type 1 Diabetes Usually diagnosed
More informationType 2 diabetes Definition
Type 2 diabetes Definition Type 2 diabetes is a lifelong (chronic) disease in which there are high levels of sugar (glucose) in the blood. Type 2 diabetes is the most common form of diabetes. Causes Diabetes
More informationG:\ CDM\BHCIG Diabetes Pathway FINAL September 05.doc 1
G:\ CDM\BHCIG Diabetes Pathway FINAL September 05.doc 1 BHCiG: TYPE 2 DIABETES MANAGEMENT PATHWAY MODEL INTRODUCTION What is the aim of the model? To improve the capacity of primary care health practitioners
More informationKaren Kovach M.S, R.D Chief Scientific Officer Weight Watchers International Inc.
Waking up to real solutions to Chronic Disease: Tackling obesity can reduce the burden of chronic disease and deliver substantial cost savings to struggling European healthcare systems Karen Kovach M.S,
More informationObesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000
P F I Z E R F A C T S Obesity in the United States Workforce Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000 p p Obesity in The United States Workforce One
More informationAn Overview and Guide to Healthy Living with Type 2 Diabetes
MEETING YOUR GOALS An Overview and Guide to Healthy Living with Type 2 Diabetes MEETING YOUR GOALS This brochure was designed to help you understand the health goals to live a healthy lifestyle with type
More informationConnecticut Diabetes Statistics
Connecticut Diabetes Statistics What is Diabetes? State Public Health Actions (1305, SHAPE) Grant March 2015 Page 1 of 16 Diabetes is a disease in which blood glucose levels are above normal. Blood glucose
More informationPUBLIC HEALTH PROGRAMME GUIDANCE DRAFT SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE PUBLIC HEALTH PROGRAMME GUIDANCE DRAFT SCOPE 1 Guidance title Guidance for primary care services and employers on the management of long-term sickness
More informationPolycystic ovary syndrome: what it means for your long-term health
Polycystic ovary syndrome: what it means for your long-term health Information for you Published in February 2005, minor amendments in June 2005 Revised 2009 What is polycystic ovary syndrome? Polycystic
More informationCHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications
CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)
More informationNutrition Therapy in Diabetes Mellitus. Dorothy Debrah Diabetes Specialist Dietitian University Hospital, Llandough. Wales, UK February 2012
Nutrition Therapy in Diabetes Mellitus. Dorothy Debrah Diabetes Specialist Dietitian University Hospital, Llandough. Wales, UK February 2012 University Hospital Llandough DIABETES MELLITUS. Definition:
More informationType 1 Diabetes ( Juvenile Diabetes)
Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.
More information1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome
More informationTreating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference
Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence
More informationAm I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE
NATIONAL DIABETES INFORMATION CLEARINGHOUSE Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes U.S. Department of Health and Human Services National Institutes of Health
More informationDiabetes. C:\Documents and Settings\wiscs\Local Settings\Temp\Diabetes May02revised.doc Page 1 of 12
Diabetes Introduction The attached paper is adapted from the initial background paper on Diabetes presented to the Capital and Coast District Health Board Community and Public Health Advisory Committee
More informationStatistics of Type 2 Diabetes
Statistics of Type 2 Diabetes Of the 17 million Americans with diabetes, 90 percent to 95 percent have type 2 diabetes. Of these, half are unaware they have the disease. People with type 2 diabetes often
More informationScottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group
Scottish Diabetes Survey 2013 Scottish Diabetes Survey Monitoring Group Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 18 Duration of Diabetes... 18
More informationCardiovascular Disease Risk Factors
Cardiovascular Disease Risk Factors Risk factors are traits and life-style habits that increase a person's chances of having coronary artery and vascular disease. Some risk factors cannot be changed or
More informationPRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION
Hull & East Riding Prescribing Committee PRESCRIBING GUIDELINES FOR LIPID LOWERING TREATMENTS for SECONDARY PREVENTION For guidance on Primary Prevention please see NICE guidance http://www.nice.org.uk/guidance/cg181
More informationDiabetes for CNAs. This course has been awarded two (2.0) contact hours. This course expires on January 31, 2017.
Diabetes for CNAs This course has been awarded two (2.0) contact hours. This course expires on January 31, 2017. Copyright 2005 by RN.com. All Rights Reserved. Reproduction and distribution of these materials
More informationType 2 Diabetes Mellitus and Insulin resistance syndrome in Children
Type 2 Diabetes Mellitus and Insulin resistance syndrome in Children Anil R Kumar MD Pediatric Endocrinology MCV/VCU, Richmond VA Introduction Type 2 diabetes mellitus (T2 DM) has increased in children
More informationPowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY 12a FOCUS ON Your Risk for Diabetes Your Risk for Diabetes! Since 1980,Diabetes has increased by 50 %. Diabetes has increased by 70 percent
More informationTrends in Prescribing of Drugs for Type 2 Diabetes in General Practice in England (Chart 1) Other intermediate and long-acting insulins
Type 2 Diabetes Type 2 diabetes is the most common form of diabetes, accounting for 90 95% of cases. 1 Charts 1 and 2 reflect the effect of increasing prevalence on prescribing and costs of products used
More informationDiabetes, Type 2. RelayClinical Patient Education Sample Topic Diabetes, Type 2. What is type 2 diabetes? How does it occur?
What is type 2 diabetes? Type 2 diabetes is a disorder that happens when your body does not make enough insulin or is unable to use its own insulin properly. The inability to use insulin is called insulin
More informationDiabetes Fundamentals
Diabetes Fundamentals Prevalence of Diabetes in the U.S. Undiagnosed 10.7% of all people 20+ 23.1% of all people 60+ (12.2 million) Slide provided by Roche Diagnostics Sources: ADA, WHO statistics Prevalence
More informationType 2 Diabetes : Factsheet. Tower Hamlets Joint Strategic Needs Assessment
Type 2 Diabetes : Factsheet Tower Hamlets Joint Strategic Needs Assessment UPDATED November 2015 Executive Summary Diabetes is a serious long-term illness. Severe complications can occur if diabetes and
More informationDiabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat?
Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat? After eating, most food is turned into glucose, the body s main source of energy. 1 Normal Blood
More informationProtein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
More informationDiabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
International Diabetes Federation Diabetes Background Information Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
More informationIs Insulin Effecting Your Weight Loss and Your Health?
Is Insulin Effecting Your Weight Loss and Your Health? Teressa Alexander, M.D., FACOG Women s Healthcare Associates www.rushcopley.com/whca 630-978-6886 Obesity is Epidemic in the US 2/3rds of U.S. adults
More informationwhat is diabetes? Talking diabetes No.42
Talking diabetes No.42 what is diabetes? Revised 2012 Diabetes is the name given to a group of different conditions in which there is too much glucose (sugar) in the blood. The pancreas either cannot make
More informationScottish Diabetes Survey
Scottish Diabetes Survey 2011 Scottish Diabetes Survey Monitoring Group Foreword The Scottish Diabetes Survey 2011 data reflects many aspects of the quality of diabetes care across the whole of Scotland.
More informationDiabetes and Heart Disease
Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the
More informationLearn about Diabetes. Your Guide to Diabetes: Type 1 and Type 2. You can learn how to take care of your diabetes.
Learn about Diabetes You can learn how to take care of your diabetes and prevent some of the serious problems diabetes can cause. The more you know, the better you can manage your diabetes. Share this
More informationESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease
Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening
More informationModern Standards and Service Models. national service framework. Diabetes. National Service Framework for Diabetes: Standards
Modern Standards and Service Models Diabetes national service framework National Service Framework for Diabetes: Standards National Service Framework for Diabetes Contents Foreword 2 Executive Summary
More informationType 2 Diabetes. Tabinda Dugal GP Day 4/05/16
Type 2 Diabetes Tabinda Dugal GP Day 4/05/16 Diabetes Diabetes.a growing health crisis in Britain 869m per year 10% of NHS budget Projections.. 5 million by 2025 Youngest patient? T2DM Type 2 diabetes
More informationNova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:
More informationThe Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
More informationDIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria
DIABETES MELLITUS By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria What is Diabetes Diabetes Mellitus (commonly referred to as diabetes ) is a chronic medical
More informationwhat is diabetes? What actually goes wrong? Talking diabetes No.42
Talking diabetes No.42 what is diabetes? Diabetes is the name given to a group of different conditions in which there is too much glucose in the blood. The pancreas either cannot make insulin or the insulin
More informationBarriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
More informationWHAT DOES DYSMETABOLIC SYNDROME MEAN?
! WHAT DOES DYSMETABOLIC SYNDROME MEAN? Dysmetabolic syndrome (also referred to as syndrome X, insulin resistance syndrome, and metabolic syndrome ) is a condition in which a group of risk factors for
More informationDiabetes Complications
Managing Diabetes: It s s Not Easy But It s s Worth It Presenter Disclosures W. Lee Ball, Jr., OD, FAAO (1) The following personal financial relationships with commercial interests relevant to this presentation
More informationDiagnosis, classification and prevention of diabetes
Diagnosis, classification and prevention of diabetes Section 1 1 of 4 Curriculum Module II 1 Diagnosis, classification and presentation of diabetes Slide 2 of 48 Polyurea Definition of diabetes Slide 3
More informationLambeth and Southwark Action on Malnutrition Project (LAMP) Dr Liz Weekes Project Lead Guy s & St Thomas NHS Foundation Trust
Lambeth and Southwark Action on Malnutrition Project (LAMP) Dr Liz Weekes Project Lead Guy s & St Thomas NHS Foundation Trust Page 0 What is the problem? Page 1 3 million (5 % population) at risk of malnutrition
More informationADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes
ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes Effects of a fixed combination of the ACE inhibitor, perindopril,
More informationUnderstanding diabetes Do the recent trials help?
Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.
More informationTechnology Assessment
Technology Assessment Lifestyle Interventions for Four Conditions: Type 2 Diabetes, Metabolic Syndrome, Breast Cancer, and Prostate Cancer Technology Assessment Program Prepared for: Agency for Healthcare
More informationAdult Weight Management Training Summary
Adult Weight Management Training Summary The Commission on Dietetic Registration, the credentialing agency for the Academy of Nutrition and Dietetics Marilyn Holmes, MS, RDN, LDN About This Presentation
More informationMetabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
More informationDiabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes.
Diabetes Brief What is Diabetes? Diabetes mellitus is a disease of abnormal carbohydrate metabolism in which the level of blood glucose, or blood sugar, is above normal. The disease occurs when the body
More informationNational Assembly for Wales: Health and Social Care Committee
2 Ashtree Court, Woodsy Close Cardiff Gate Business Park Cardiff CF23 8RW Tel: 029 2073 0310 wales@rpharms.com www.rpharms.com 18 th October 2011 Submission to: Call for Evidence: Response from: National
More informationClinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
More informationdefinition and diagnosis of diabetes mellitus and intermediate hyperglycemia Report of a WHO/IDF Consultation
definition and diagnosis of diabetes mellitus and intermediate hyperglycemia Report of a WHO/IDF Consultation WHO Library Cataloguing-in-Publication Data Definition and diagnosis of diabetes mellitus and
More informationThe New Complex Patient. of Diabetes Clinical Programming
The New Complex Patient as Seen Through the Lens of Diabetes Clinical Programming 1 Valerie Garrett, M.D. Medical Director, Diabetes Center at Mission Health System Nov 6, 2014 Diabetes Health Burden High
More informationAlzheimer s disease and diabetes
1007029 CM1053CS Alzheimer s disease and diabetes Nearly 21 million Americans in the United States have diabetes, a disease that makes the body less able to convert sugar to energy. More than 6 million
More informationBlack and Minority Ethnic Groups Author/Key Contact: Dr Lucy Jessop, Consultant in Public Health, Buckinghamshire County Council
Black and Minority Ethnic Groups Author/Key Contact: Dr Lucy Jessop, Consultant in Public Health, Buckinghamshire County Council Introduction England is a country of great ethnic diversity, with approximately
More informationHEALTH UPDATE. Polycystic Ovary Syndrome (PCOS)
HEALTH UPDATE PO Box 800760 Charlottesville, VA 22908 Gynecology: (434) 924-2773 Polycystic Ovary Syndrome (PCOS) What is it? An endocrine (hormonal) disorder. Because there is such variability in how
More informationD I D Y O U K N O W? D I A B E T E S R E S O U R C E G U I D E. Blindness Heart Disease Strokes Kidney Failure Amputation
D I D Y O U K N O W? D I A B E T E S R E S O U R C E G U I D E Diabetes is a serious disease that can lead to Blindness Heart Disease Strokes Kidney Failure Amputation Diabetes kills almost 210,000 people
More informationThis information explains the advice about diabetes in pregnancy that is set out in NICE guideline NG3.
Information for the public Published: 25 February 2015 nice.org.uk About this information NICE guidelines provide advice on the care and support that should be offered to people who use health and care
More informationInstitute of Applied Health Sciences. University of Aberdeen DATABASE REVIEW. Grampian University. Hospitals NHS Trust GRAMPIAN DIABETES
DATABASE REVIEW Grampian University Hospitals NHS Trust GRAMPIAN DIABETES SERVICES DATABASE Page 1 Contents Contents 2 Introduction 3 History 3 Overview of Database 3 Database Structure 4 Main Table Summary
More informationThe Family Library. Understanding Diabetes
The Family Library Understanding Diabetes What is Diabetes? Diabetes is caused when the body has a problem in making or using insulin. Insulin is a hormone secreted by the pancreas and is needed for the
More informationCME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus
CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing
More informationJill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
More informationManaging diabetes in the post-guideline world. Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ)
Managing diabetes in the post-guideline world Dr Helen Snell Nurse Practitioner PhD, FCNA(NZ) Overview Pathogenesis of T2DM Aims of treatment The place of glycaemic control Strategies to improve glycaemic
More informationTERMS FOR UNDERSTANDING YOUR TYPE 2 DIABETES. Definitions for Common Terms Related to Type 2 Diabetes
TERMS FOR UNDERSTANDING YOUR TYPE 2 DIABETES Definitions for Common Terms Related to Type 2 Diabetes TYPE 2 DIABETES AND BLOOD SUGAR 1-3 This list of terms may help you beter understand type 2 diabetes,
More informationReview of diabetes care in London Health and Environment Committee
The London Assembly s Health and Environment Committee intends to review diabetes care in London. Aim of review The purpose of this review is for the Committee to understand the extent of diabetes prevalence
More informationHigh Blood Sugar. Printable Materials
Printable Materials Activity Card #1 Symptoms of High Blood Sugar or Pre-Diabetes Symptoms People often don t know they have high blood sugar or pre-diabetes. There are no symptoms and pre-diabetes can
More informationSample Service Specifications
Sample Service Specifications SSS 1: Care of people with diabetes as part of essential services Service Description Certain aspects of diabetes care fall within the essential services element of the community
More informationOverview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health
Overview of Diabetes Management By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health Objectives: Describe the pathophysiology of diabetes. From a multiorgan systems viewpoint. Identify the types of diabetes.
More informationSKAD462 (SQA Unit Code - FG6J 04) Apply the principles of nutrition to support client goals as part of an exercise and physical activity programme
Apply the principles of nutrition to support client goals as part of an exercise and physical activity programme Overview Nutrition affects general health status as well as physical performance. There
More informationKansas Behavioral Health Risk Bulletin
Kansas Behavioral Health Risk Bulletin Kansas Department of Health and Environment November 7, 1995 Bureau of Chronic Disease and Health Promotion Vol. 1 No. 12 Diabetes Mellitus in Kansas Diabetes mellitus
More informationBackground (cont) World Health Organisation (WHO) and IDF predict that this number will increase to more than 1,3 million in the next 25 years.
Diabetes Overview Background What is diabetes Non-modifiable risk factors Modifiable risk factors Common symptoms of diabetes Early diagnosis and management of diabetes Non-medical management of diabetes
More informationBaskets of Care Diabetes Subcommittee
Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level
More informationTrend tables. Health Survey for England. A survey carried out on behalf of the Health and Social Care Information Centre. Joint Health Surveys Unit
Health Survey for England 2013 Trend tables 2 A survey carried out on behalf of the Health and Social Care Information Centre Joint Health Surveys Unit Department of Epidemiology and Public Health, UCL
More informationPrevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012
Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012 In 2002, SETMA began a relationship with Joslin Diabetes
More informationPrescribing for Diabetes in England - An Update: 2002-2008 An analysis of volume, expenditure and trends
Prescribing for Diabetes in England - An Update: 2002-2008 An analysis of volume, expenditure and trends June 2009 diabetes Health Intelligence YHPHO YORKSHIRE & HUMBER PUBLIC HEALTH OBSERVATORY Diabetes
More informationObesity and ethnicity
Obesity and ethnicity January 2011 NOO Obesity and ethnicity 2 NOO is delivered by Solutions for Public Health Contents Executive summary...3 Introduction...3 Defining ethnicity...4 Population overview...4
More information